Protective effect of ghrelin on sodium valproate-induced liver injury in rat

Protective effect of ghrelin on sodium valproate-induced liver injury in rat

Автор: Sadeghi Niaraki Mandana, Nabavizadeh Fatemeh, Vaezi Gholam H., Alizadeh Ali M, Nahrevanian Hossein, Moslehi Azam, Azizian Saleh

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 1 т.9, 2013 года.

Бесплатный доступ

Ghrelin is a peptide that has protective effects on many tissues injury. It has anti-inflammatory and anti-oxidant effects. Sodium valproate is widely used anticonvuisant and anti-depression drug with hepatotoxic side effects. The aim of this study was to evaluated the protective role of ghrelin in liver toxicity due to sodium valproate overdose. Eighteen rats were used in this study and divided in to three groups, containing: control, sodium valproate, and sodium valproate and ghrelin groups. Nitric oxide (NO), prostaglandin E2 (PGE2) and hepatic enzymes AST (aspartate aminotransferase) and ALT (alanine aminotransferase), were assessed and histologic study of liver were performed as indicators of liver damage following sodium valproate toxicity. This study showed the ghrelin decreased ALT and AST to the normal level. Our results show that ghrelin significantly increased NO metabolites and decreased PGE2 level comparison with sodium valproate group, but had no significant change compared to the control group. we showed that ghrelin administration inhibited liver injury in rats due to sodium valproate toxicity.

Еще

Ghrelin, liver injury, nitric oxide(no), prostaglandin e2(pge2), sodium valproate

Короткий адрес: https://sciup.org/14323727

IDR: 14323727

Список литературы Protective effect of ghrelin on sodium valproate-induced liver injury in rat

  • Ariyasu, H., Takaya, K., Tagami, T., Ogawa, Y., Hosoda, K., Akamizu, T., Suda, M., Koh, T., Natsui, K., Toyooka, S., Shirakami, G., Usui, T., Shimatsu, A., Doi, K., Hosoda, H., Kojima, M., Kangawa, K., Nakao, K. (2001). Stomach Is a Major Source of Circulating Ghrelin, and Feeding State Determines Plasma Ghrelin-Like Immunoreactivity Levels in Humans. Journal of Clinical Endocrinology & Metabolism., 86, 4753-4758.
  • Bellringer, ME., Rahman. K., Coleman, R. (1988). Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes. Biochem J., 249, 513-519.
  • Bosetti, F., Weerasinghe, GR., Rosenberger, T.A., Rapoport, S.I. (2003). Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. Journal of Neurochemistry., 85, 690-696.
  • Brzozowski, T., Konturek, P., Konturek, S., Kwiecie, S., Drozdowicz, D., Bielanski, W., Pajdo, R., Ptak, A., Nikiforuk, A., Pawlik, W.W., Hahn, E.G. (2004). Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regulatory Peptides., 120, 39-51.
  • Carlini, V., Monzon, M., Varas, M., Cragnolini, A., Schioth, H., Scimonelli, T., de Barioglio, S.R. (2002). Ghrelin increases anxiety-like behavior and memory retention in rats. Biochemical and Biophysical Research Communications., 299, 739-743.
  • Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M., Suganuma, T., Matsukura, S., Kangawa, K., Nakazato, M. (2000). Ghrelin a novel growth hormone-releasing acylated peptide is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology., 141, 4255-4261.
  • Dlta, C., Jacob, L.Z. (1988). Valproic Acid and the liver review. Clinical Chemistry., 34, 890-897.
  • EI Eter, E., Al Tuwaijiri, A., Hagar, H., Arafa, M. (2007). In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. Journal of Gastroenterology and Hepatology., 22, 1791-1799.
  • Golestan Jahromi, M., Nabavizadeh, F., Vahedian, J., Nahrevanian, H., Dehpour, A.R., Mehrjardi, A.Z. (2010). Protective effect of ghrelin on acetaminophen-induced liver injury in rat. Peptides Journal., 31, 2114-2117.
  • Ishak, K., Baptista, A., Bianchi, L., Callea, F., Gudat, F., Denk, H., Desmet, V., Korb, B., Macsween, R., Philips, M.J., Portmann, B.G., Poulsen, H., Scheuer, P.J., Schmid, M., Thaler, H. (1995). Histological grading and staging of chronic hepatits. J. hepatology., 22, 696-699.
  • Jaeschke, H., Gores, G., Cederbaum, A., Hinnson, J., Pessayre, D., Lemasters, J. (2002). Mechanisms of hepatotoxicity. Toxicological Sciences. 65, 166-176.
  • James, L., Mayeux, P., Hinson, J. (2003). Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition., 31, 1499-1506.
  • Kojima, M., Hosoda, H., Kangawa, K. (2004). Ghrelin a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Practice & Research Clinical Endocrinology & Metabolism., 18, 517-530.
  • Konturek, P., Brzozowski, T., Walter, B., Burnat, G., Hess, T., Hahn, E., et al. (2006). Ghrelin-induced gastroprotection against ischemia-reperfusion injury involves an activation of sensory afferent nerves and hyperemia mediated by nitric oxide. European Journal of Pharmacology., 536, 171-181.
  • Liston, H.I., Makowitz, J.S., De Vane C.I. (2001). Drug glucuronidation in clinical psychopharmacology. J. Clin Psychopharmacol., 21, 500-515.
  • Li, W.G., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L.L., McCormick, M.L., Sigmund, C.D., Tang, C., Weintraub, N.L. (2004). Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation., 109, 2221-2226.
  • Martinez, F., Abril, E.R., Earnest, D.L., Watson, R.R. (1992). Ethanol and cytokine secretion. Alcohol., 9, 455-458.
  • Moreno, M., Chaves, J., Sancho-Bru, P., Ramalho, F., Ramalho, L., Mansego, M., Ivorra, C., Dominguez, M., Conde, L., Millán, C., Marí, M., Colmenero, J., Lozano, J.J., Jares, P., Vidal, J., Forns, X., Arroyo, V., Caballería, J., Ginès, P., Bataller, R. (2010). Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology., 51, 974-985.
  • Nahrevanian, H., Hajihosseini, R., Arjmand, M., Farahmand, M., Ghasemi, F. (2009). Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with leishmania major. Southeast Asian Journal of Tropical Medicine and Public Health., 40(6), 1188-1198.
  • Raoj, S., Bazinet, R.P., Rapoport, S.I., Lee, H.J. (2007). Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-Kappa B DNA binding activity and COX-2 mRNA. Bipolar Disord., 9, 513-20.
  • Sibilia, V., Rindi, G., Pagani, F., Rapetti, D., Locatelli, V., Torsello, A., Campanini, N., Deghenghi, R., Netti, C. (2003). Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanism of action. Endocrinology., 144, 353-359.
  • Silva, M.F., Ruiter, J.P., Overmars, H., Bootsma, A.H., Van Gennip, A.H., Jacobs, C., Duran, M., Dealmeida, T.I., Wanders, R.J. (2002). Complete beta oxidation of valproate: cleavage of 3-oxovalproyl-coA by a mitochondrial 3-oxovalproyl-coA thiolase. Biochem J., 15, 755-760.
  • Shaat, E.A., Samia, M.A., Madkour, S. (2006). Effect of L-Carntine and deferoxamine on hepatotoxicity, erythrocyte ergothioneine and testicular testosterone synthesis in sodium valproate-treated rats. Bull. Alex. Fac. Med., 42, 123-124.
  • Shiiya, T., Nakazato, M., Mizuta, M., Date, Y., Mondal, M., Tanaka, M., Nozoe, S., Hosoda, H., Kangawa, K., Matsukura, S. (2002). Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. Journal of Clinical Endocrinology & Metabolism., 87, 240-244.
  • Slominany, B.L., Slomiany, A. (2009). Involvement of constitutive nitric oxide synthase in ghrelin-induced cytosolic phospholipase A2 activation in gastric mucosal cell protection against ethanol cytotoxicity. Inflammopharmacol., 17, 245-253.
  • Tesauro, M., Schinzari, F., Iantomo, M., Rizza, S., Melina, D., Lauro, D., Cardillo, C. (2005). Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation., 112, 2986-2992.
  • Tong, V., Teng, X.W., Chang, T.K.H., Abbott, F.S. (2005). Valproic Acid I: Time Course of Lipid Peroxidation Biomarkers, Liver Toxicity, and Valproic Acid Metabolite Levels in Rats. Toxicological Sciences., 86, 427-435.
  • Weikel, J., Wichniak, A., Ising, M., Brunner, H., Friess, E., Held, K., Mathias, S., Schmid, D.A., Uhr, M., Steiger, A. (2003). Ghrelin promotes slow-wave sleep in humans. American Journal of Physiology-Endocrinology and Metabolism., 284, 407-415.
  • Yada, T., Kaiya, H., Mutoh, K., Azuma, T., Hyodo, S., Kangawa, K. (2006). Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. Journal of Endocrinology., 189, 57-65.
  • Yoshihara, F., Kojima, M., Hosoda, H., Nakazato, M., Kangawa, K. (2002). Ghrelin: a novel peptide for growth hormone release and feeding regulation. Current Opinion in Clinical Nutrition & Metabolic Care., 5, 391-395.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp